Skip to main content
. 2021 Jun 11;9:e11627. doi: 10.7717/peerj.11627

Figure 6. The verification of prognostic FRlncRNAs signature in validation cohort.

Figure 6

(A) The KM curves of validation cohort revealed that the high-risk group had statistical differences on OS period compared with the low-risk group (P < 0.05). Univariate (B) and multivariate (C) COX regression for the FRlncRNAs signature established by training cohort. (D) AUC of ROC curves validated the predicted performance of signature in the validation cohort.